ENGN Q3 2025 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena

ENGNenGene Holdings Inc.

$359M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$130,000

Operating Income

$30M

Net Income

-$29M

EPS (Diluted)

$-0.57

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$246M

Total Liabilities

$45M

Stockholders' Equity

$201M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$130,000	-$82,000	-58.5%
Operating Income	$30M	-$17M	+278.7%
Net Income	-$29M	-$14M	-104.9%